TRANSCEND CAPITAL ADVISORS, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1776082 MADISON, NJ

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$498,035

+$208,998 QoQ

Shares Held

2,955

+34.7% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#476

of 772 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TRANSCEND CAPITAL ADVISORS, LLC holds $1,617,958 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (30.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	61,251	$571,471
2	NBIX	Neurocrine Biosciences Inc This page	2,955	$498,035
3	TEVA	Teva Pharmaceutical Industries Ltd	12,319	$417,367
4	AQST	Aquestive Therapeutics, Inc.	31,511	$131,085

All Filings in NBIX

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$498,035	2,955	+34.7%	Shares	Sole	2026-08-04
2026-03-31	$289,037	2,194	-12.9%	Shares	Sole	2026-05-13
2025-12-31	$357,269	2,519	+13.5%	Shares	Sole	2026-01-23
2025-09-30	$311,643	2,220	—	Shares	Sole	2025-11-04
No filing history on record for this holder in this stock.